Fulgent Genetics, Inc.
FLGT
$18.82
-$0.74-3.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.71% | -1.99% | -3.02% | -5.42% | -21.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.71% | -1.99% | -3.02% | -5.42% | -21.20% |
| Cost of Revenue | -0.44% | -4.60% | -8.77% | -15.26% | -18.91% |
| Gross Profit | 5.30% | 2.64% | 9.09% | 15.44% | -24.74% |
| SG&A Expenses | -1.11% | -4.69% | 9.56% | 0.53% | -5.63% |
| Depreciation & Amortization | 1.25% | 1.53% | 0.43% | -0.64% | 4.07% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.27% | -1.95% | 1.45% | -5.20% | -9.76% |
| Operating Income | 0.49% | 1.83% | -18.56% | 4.25% | -113.47% |
| Income Before Tax | 70.39% | 70.15% | -203.31% | -142.72% | -328.72% |
| Income Tax Expenses | -226.78% | -805.72% | -752.13% | 140.58% | 152.32% |
| Earnings from Continuing Operations | 75.83% | 74.99% | -164.64% | -240.30% | -530.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -84.95% | -85.00% | 374.88% | 390.47% | 365.16% |
| Net Income | 75.43% | 74.55% | -159.76% | -235.71% | -540.33% |
| EBIT | 0.49% | 1.83% | -18.56% | 4.25% | -113.47% |
| EBITDA | -3.00% | 0.33% | -39.73% | -9.30% | -4,776.29% |
| EPS Basic | 75.99% | 74.89% | -158.64% | -233.61% | -528.03% |
| Normalized Basic EPS | -4.05% | 6.14% | 14.71% | 47.47% | -46.04% |
| EPS Diluted | 76.00% | 74.90% | -157.14% | -231.94% | -517.64% |
| Normalized Diluted EPS | -4.05% | 6.14% | 14.71% | 47.52% | -42.28% |
| Average Basic Shares Outstanding | 2.20% | 1.51% | 0.90% | 0.42% | -0.28% |
| Average Diluted Shares Outstanding | 2.20% | 1.51% | 0.90% | -0.16% | -1.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |